Host-Microbiome Interactions Mediated by Phenolic Metabolites in Chronically Critically Ill Patients

• Main Authors: Ekaterina Chernevskaya, Natalia Klimenko, Alisa Pautova, Irina Buyakova, Alexander Tyakht, Natalia Beloborodova
• Format: Article
• Language: English
• Published: MDPI AG 2021-02-01
• Series: Metabolites
• Subjects: host‑microbe interactions; microbiome; metabolomics; gut bacteria; 16S rRNA; GC‑MS
• Online Access: https://www.mdpi.com/2218-1989/11/2/122

The community structure and metabolic potential of gut microbiome is not well investigated, especially in chronically critically ill patients with prolonged dependence on support systems after severe brain disorders. Microbial phenolic metabolites can target the brain function by the direct and indirect modulation of inflammation. The aim of this study was to investigate the features of the gut microbiota and profile of certain metabolites in the progression and reversibility of neurological disorders in chronically critically ill patients. Fecal samples were collected in dynamics from such patients (<i>n</i> = 44) and analyzed using 16S rRNA sequencing. Serum microbial and mitochondrial metabolites were measured by GC-MS and compared with the biomarkers and clinical neurological scores. The identified associations between specific bacterial taxa in fecal samples, neurological status and serum levels of metabolites suggest that impacts on specific members of the gut microbiota and their metabolism might be a promising tool for regulating brain function in future.